Materialise announced a collaboration with Exactech to provide advanced treatment options for patients with severe shoulder defects. Exactech will include the Materialise Glenius solution in their portfolio, enabling surgeons to help patients with personalized implants in Europe and Australia. Shoulder replacements account for approximately 60% of orthopedic extremity procedures and represent one of the fastest-growing markets in orthopedics.

With increasing expectations of patient satisfaction, surgeons are looking for treatment options to improve clinical outcomes even for challenging cases. Orthopedic surgeons can leverage Materialise's personalized implants to treat patients with substantial glenoid bone loss for whom standard and augmented reverse shoulder implants would not lead to sustainable results. Materialise's Clinical Engineers design each Glenius implant based on the patient's unique anatomy using 3D data, simulation, and artificial intelligence.

Optimizing the fixation and stability of the implant while maximizing bone preservation aims for more predictable clinical outcomes in the most challenging eroded glenoid scenarios.